1

Ypsomed

Ypsomed
Leadership team

Mr. Simon Michel (CEO & Member of the Board)

Mr. Niklaus Ramseier (Chief Financial Officer)

Mr. Frank Mengis (COO & Sr. VP of Operations)

Products/ Services
Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Burgdorf, Bern, Switzerland
Established
2003
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
SWX:YPSN
Social Media
Overview
Location
Summary
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
History

Ypsomed has been in the medical technology business for more than 30 years. Founded in 1988 as a medical technology start-up in Burgdorf near Bern, Ypsomed became a world market leader for automatic injections and infusion systems for self-medication in a short time.

Mission
Our mission is to improve people’s lives by offering the highest quality products and services to empower our customers in their healthcare.
Vision
Our vision is to be the global leader in self-injection systems by providing solutions to meet our customers’ individual needs.
Key Team

Thomas Kutt (Head of Investor Relations)

Dr. Beat Maurer (Chief Legal Officer)

Mr. Michael Zaugg (Chief Corp. Officer)

Ms. Ulrike Bauer (Chief Bus. Officer)

Mr. Sebastien Delarive (Chief Bus. Officer)

Recognition and Awards
Ypsomed has won numerous awards over the years, including the Innovation Award Switzerland, the Technology Award Bern and the Innovators Award in Life Science 2017. Ypsomed is also a certified Swiss Made brand.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Ypsomed
Leadership team

Mr. Simon Michel (CEO & Member of the Board)

Mr. Niklaus Ramseier (Chief Financial Officer)

Mr. Frank Mengis (COO & Sr. VP of Operations)

Products/ Services
Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Burgdorf, Bern, Switzerland
Established
2003
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
SWX:YPSN
Social Media